A new vaccine for shingles is now recommended for adults aged 50 and older. Following the Food and Drug Administration (FDA) approval of Shingrix in October 2017, the Advisory Committee […]
WATCH THIS: Presidential Address, Keynote Highlight Triological Society 2015 Combined Sections Meeting Kickoff
Triological President Derald E. Brackmann, MD, takes a historical look at glomus tumors and neurotology, and Pulitzer Prize winner David Oshinsky, PhD, discusses how the March of Dimes and the […]
Slowing the Rise of Oropharyngeal Cancers
Diagnosis of Supraglottitis in the Post-Immunization Era
What are the demographics, presentation, interventions and outcomes of acute supraglottitis in the era following widespread immunization against Haemophilus influenza type b? Background: The overall incidence of acute supraglottitis has decreased […]
Promise for Recurrent Respiratory Papillomatosis: Pediatric otolaryngologists have high hopes for the HPV vaccine
Optimism is growing that a new HPV vaccine will drastically decrease the number of cases of pediatric recurrent respiratory papillomatosis (RRP), a rare but devastating disease.
Researchers Close In on Ear Infection Vaccine
ENToday recently reported on a move toward more conservative use of antibiotics and ventilation tubes in the treatment of pediatric ear infections.
Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
Recurrent respiratory papillomatosis (RRP) remains a devastating disease for pediatric patients.
Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
Recurrent respiratory papillomatosis (RRP) begins with a pretty small virus, relatively speaking, but it can lead to some pretty big problems for both the patient and the treating physician.